IMPORTANT DEADLINES

Abstract Submission 11/15/07

Pre Registration 1/25/08
Hotel Reservations 2/1/08

 

IMPORTANT DATES

Meeting 2/24/08-2/27/08


BALTIMORE RESOURCES




 

 

Continuing Medical Education/Continuing Education Information


To claim your credit and print your certificate for participating in the 2008 ASM Biodefense and Emerging Diseases Research Meeting, please follow these steps:

Once you have claimed your credit for this activity it will be added to your transcript which can be viewed at any time by logging into the ASM CE Portal and selecting the “Transcript” button at the top right of any page in the portal..

Should you have questions or need additional information about the continuing education component of this program, please email cmeservices@asmusa.org or you may contact Bianca Blanks by phone at 202.942.9223.

You will be need to complete a short survey for each session your are claiming CME for to generate your Certificate of Credit.  You are responsible for recording your attendance by completing and signing a CME Credit and Attendance Form at the meeting.

 

The following ASM Biodefense Research Meeting session types offer continuing medical education credit. Individual sessions earning credit will be annotated in the Final Program with the CME symbol.

Session Type    Maximum Contact Hours
Focus Sessions    2.5
Plenary Sessions    3.0
Opening General Session    1.5
Concurrent Symposia    2.0
Poster Podium Presentations   1.0
Discussion/Q&A Session   1.0

 


Physicians and Microbiologists

The American Society for Microbiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The American Society for Microbiology takes responsibility for the content, quality and scientific integrity of this CME activity.

 

The American Society for Microbiology designates this activity for a maximum of 23.5 AMA PRA Category 1 Credits™. Each physician should claim only those credits that he/she actually spent in the educational activity.

 

Diplomates of the American Board of Medical Microbiology, Diplomates of the American Board of Medical laboratory Immunology, and Registrants of the National Registry of Microbiologists may earn AMA PRA Category 1 Credits™ toward re-certification. Each professional should only claim those credits that he/she actually spent in the educational activity.

 

Disclosure of Relevant Financial Relationships and Unlabeled/Unapproved Uses of Drugs or Devices

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the ASM requires that all faculty members participating in continuing education activities sponsored by ASM disclose any relevant financial relationships related to the content of their presentation(s), as well as any off-label uses of a drug.  You can view these disclosures in the Final Program.  The intent of this policy is not to prevent a speaker with significant financial interest or other relationship from making a presentation, but rather to provide participants with information on which they can base their own judgments.  It remains for the audience to determine if the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion.  When unlabeled uses are discussed, these are also indicated.

 

Educational Disclaimer

The primary purpose of the ASM Biodefense Research Meeting is education. Information presented, as well as publications, technologies, products, and/or services discussed, are intended to inform you about the knowledge, techniques, and experiences of professionals who are willing to share such information with colleagues.  A diversity of professional opinions exists in the fields discussed at the ASM Biodefense Research Meeting and the views of the faculty are offered solely for educational purposes. Faculty’s views neither represent those of ASM nor constitute endorsement by the association.  The ASM disclaims any and all liability for damages to any individual attending the ASM Biodefense Research Meeting and for all claims which may result from the use of this information, publications, technologies, products, and/or services at the ASM Biodefense Research Meeting.